Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced today that the United States Patent and Trademark Office has granted the Company a new United States Patent entitled Methods of Administering and Enhancing Absorption of Pharmaceutical Agents. The patent covers broad claims for the delivery of macromolecules via the buccal cavity of the mouth.
